XCONOMY SAN FRANCISCO – Vir Biotechnology has joined the public markets, raising $142.9 million to support clinical tests of its infectious disease drugs.
Read the full press release here.
XCONOMY SAN FRANCISCO – Vir Biotechnology has joined the public markets, raising $142.9 million to support clinical tests of its infectious disease drugs.
Read the full press release here.